Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 8 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 10183933

    Isoindolinone inhibitors of phosphatidylinositol 3-kinase

    Vertex Pharmaceuticals Incorporated · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  2. US 10160760

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  3. US 10118904

    Triazoles for the treatment of Demyelinating Diseases

    Vertex Pharmaceuticals Incorporated · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  4. US 10093676

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  5. US 10087143

    Pyridone amides as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  6. US 10081621

    Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide

    Vertex Pharmaceuticals Incorporated · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  7. US 10076521

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  8. US 10076513

    Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  9. US 10071979

    Process of producing cycloalkylcarboxamido-indole compounds

    Vertex Pharmaceuticals Incorporated · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  10. US 10058546

    Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxo1-5-y1)-N-(1-(2,3-dihydroxypropy1)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-y1)-1H-indol-5-y1) cyclopropanecarbox-amide and administration thereof

    Vertex Pharmaceuticals Incorporated · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  11. US 10039762

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

  12. US 10039761

    Co-crystals and pharmaceutical compositions comprising the same

    Vertex Pharmaceuticals Incorporated · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

  13. US 10030024

    Imidazopyridazines useful as inhibitors of the PAR-2 signaling pathway

    Vertex Pharmaceuticals Incorporated · Granted Jul 24, 2018 · Expires Jul 19, 2038

    granted

  14. US 10023569

    Methods of preparing inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted

  15. US 10022352

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted

  16. US 9994613

    Prodrug of an ICE inhibitor

    Vertex Pharmaceuticals Incorporated · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted

  17. US 9987284

    Substituted benzooxadiazole DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 5, 2018 · Expires May 31, 2038

    granted

  18. US 9974781

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted May 22, 2018 · Expires May 17, 2038

    granted

  19. US 9963478

    Mannose derivatives for treating bacterial infections

    Vertex Pharmaceuticals Incorporated · Granted May 8, 2018 · Expires May 3, 2038

    granted

  20. US 9931334

    Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  21. US 9925188

    DNA-PK inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted

  22. US 9908878

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted

  23. US 9890176

    Mannose derivatives for treating bacterial infections

    Vertex Pharmaceuticals Incorporated · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted

  24. US 9878993

    DNA-PK inhibitors for treatment of cancer

    Vertex Pharmaceuticals Incorporated · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.